Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification

Abstract

In a multicenter validation study, we developed a modified version of the HAP that predicts survival of patients with HCC treated with TACE in Europe and Asia. This system might be used to identify patients with HCC most likely to benefit from TACE in clinical practice.